Hancock Whitney’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,593
Closed -$259K 674
2022
Q1
$259K Buy
+3,593
New +$259K 0.01% 613
2020
Q2
Sell
-2,755
Closed -$427K 870
2020
Q1
$427K Buy
+2,755
New +$321K 0.02% 543

Other funds holding TDOC

Hancock Whitney's TDOC Position: Q2 2022 in Review

Hancock Whitney sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 3,593 shares — an estimated $259K sold.

Hancock Whitney first reported a position in TDOC in Q1 2020 and held it in 2 quarters. The position peaked at $427K in Q1 2020. 550 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Hancock Whitney reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Hancock Whitney sold 3,593 Teladoc Health shares in Q2 2022, an estimated $259K.
  • Hancock Whitney first reported a position in Teladoc Health in Q1 2020 and held it in 2 quarters.
  • Hancock Whitney's Teladoc Health position peaked at $427K in Q1 2020.
  • 550 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Hancock Whitney's 13F filing for Q2 2022, filed 8 Aug 2022.